Molecular Imaging in Neurology

MI-Neuro Basics - Glowing Brain Clues

• Visualizes brain physiology (blood flow, metabolism) & pathology (protein deposits) at molecular level using radiotracers.
• PET (Positron Emission Tomography):
  • Principle: Detects two coincident 511 keV gamma rays from positron annihilation. Quantitative.
  • Advantages: Higher sensitivity & spatial resolution.
  • Key Tracers:
    • $18F$-FDG (glucose metabolism)
    • Amyloid ($18F$-Florbetapir)
    • Tau ($18F$-Flortaucipir)
    • Dopamine ($18F$-DOPA)
• SPECT (Single Photon Emission Computed Tomography):
  • Principle: Detects single gamma rays from radionuclide decay.
  • Advantages: More accessible, cost-effective.
  • Key Tracers:
    • $99mTc$-HMPAO/$99mTc$-ECD (cerebral perfusion)
    • $123I$-ioflupane (DaTscan for dopamine transporters)
• 

⭐ $18F$-FDG is the most versatile radiotracer, showing glucose metabolism vital for assessing tumors, inflammation, and neurodegenerative patterns.

Degenerative Disorders MI - Fading Memories & Moves

• Alzheimer's Disease (AD)
  • FDG-PET ($^{18}$F-fluorodeoxyglucose): Shows ↓ glucose metabolism, typically in temporoparietal regions, posterior cingulate cortex, and precuneus.
  • Amyloid-PET (e.g., $^{18}$F-florbetapir, $^{18}$F-flutemetamol): Detects amyloid-β plaque burden. Positive scan supports AD pathology.
  • Tau-PET (e.g., $^{18}$F-flortaucipir): Visualizes neurofibrillary tangles (NFTs); distribution and density correlate with cognitive impairment.
  • ⭐ > Pattern of bilateral temporoparietal hypometabolism, often including posterior cingulate cortex and precuneus, on FDG-PET is characteristic of Alzheimer's disease.
• Parkinson's Disease (PD) & Parkinsonian Syndromes
  • DAT Scan ($^{123}$I-ioflupane SPECT or $^{18}$F-DOPA PET): Assesses presynaptic dopamine transporter (DAT) integrity in the striatum.
    • PD: Typically asymmetric ↓ uptake, most marked in posterior putamen initially (caudate relatively spared). 📌 "Putamen Punched first in PD".
    • Differentiates PD from essential tremor (normal DAT scan).
    • Atypical Parkinsonism (e.g., MSA, PSP): Can also show ↓ DAT uptake, patterns may vary.
• Dementia with Lewy Bodies (DLB)
  • DAT Scan: ↓ striatal uptake, similar to PD.
  • $^{123}$I-MIBG (Metaiodobenzylguanidine) Cardiac Scintigraphy: Shows ↓ cardiac sympathetic innervation. Useful to differentiate DLB (↓ uptake) from AD (normal uptake).
• Frontotemporal Dementia (FTD)
  • FDG-PET: Shows ↓ glucose metabolism in frontal and/or anterior temporal lobes.
    • Behavioral variant FTD (bvFTD): Predominantly frontal hypometabolism.
    • Semantic Dementia: Anterior temporal lobe hypometabolism (often asymmetric, left > right).

Tumors & Seizures MI - Growth & Glitch Guides

Brain Tumors: Molecular Imaging Insights

• PET Tracers:
  • $18F$-FDG PET:
    • High-grade tumors: typically show ↑ uptake (hypermetabolism).
    • Low-grade tumors: variable, often ↓ uptake (hypometabolism).
    • Differentiating recurrence vs. radiation necrosis (RN): often equivocal, as RN can also show ↑ FDG uptake.
  • Amino Acid PET (e.g., $18F$-FET, $11C$-MET, $18F$-DOPA):
    • Superior for tumor delineation, grading, and biopsy guidance.
    • Key for differentiating tumor recurrence (↑ uptake) from RN (typically ↓ or normal uptake).
    • $18F$-FET offers a high tumor-to-background ratio due to low uptake in normal brain tissue.
  • Choline PET (e.g., $18F$-FCH, $11C$-Choline):
    • Reflects ↑ cell membrane synthesis and proliferation.
• SPECT Tracers:
  • $201Tl (Thallium) and $99mTc$-Sestamibi (MIBI):
    • Assess tumor viability and grade; ↑ uptake in high-grade gliomas.

Seizures (Epilepsy): Pinpointing the Focus

• Primary Goal: Localize the epileptogenic zone (EZ) for pre-surgical evaluation.
• Ictal SPECT (e.g., $99mTc$-HMPAO, $99mTc$-ECD):
  • Tracer injected during a seizure.
  • Shows ↑ regional cerebral blood flow (rCBF) at the seizure onset zone.
  • Often analyzed using SISCOM (Subtraction Ictal SPECT Co-registered to MRI).
• Interictal $18F$-FDG PET:
  • Shows ↓ glucose metabolism (hypometabolism) in the EZ between seizures.
  • Most widely used PET technique for epilepsy, especially Temporal Lobe Epilepsy (TLE).
• Other PET Tracers (Specialized):
  • $11C$-Flumazenil ($11C$-FMZ) PET: Measures benzodiazepine receptor density, which is often ↓ in the EZ.

⭐ Amino acid PET (e.g., $18F$-FET, $11C$-MET) helps differentiate tumor recurrence from radiation necrosis, as tumors show increased uptake, while necrosis typically does not.

📌 Mnemonic: For Tumor Recurrence vs. Radiation Necrosis, Amino Acids are Ahead (FET/MET > FDG).


Flowchart: Imaging in Refractory Epilepsy 

High‑Yield Points - ⚡ Biggest Takeaways

• ¹⁸F-FDG PET shows temporoparietal hypometabolism in Alzheimer's; frontal/temporal hypometabolism in FTD.
• Amyloid PET (e.g., ¹⁸F-Florbetapir) detects amyloid plaques in Alzheimer's disease.
• Tau PET (e.g., ¹⁸F-Flortaucipir) visualizes tau pathology in tauopathies like Alzheimer's.
• DAT scans (¹²³I-Ioflupane SPECT) differentiate Parkinson's disease (↓ striatal uptake) from essential tremor.
• Brain tumors: ¹⁸F-FDG PET differentiates recurrence/necrosis. Amino acid PET (¹⁸F-FET) for better delineation.
• Epilepsy: Interictal PET shows hypometabolism at focus; ictal SPECT shows hyperperfusion.